DrFirst’s new prescription monitoring solution – TrueRx – will give the nation’s pharmacies their first-ever standardized alert system to protect against prescriber identity and prescription f...
DrFirst rolls out its latest innovation to pharmacy chains across the country
ROCKVILLE, Md.: DrFirst’s new prescription monitoring solution – TrueRx – will give the nation’s pharmacies their first-ever standardized alert system to protect against prescriber identity and prescription fraud.
Backed by AI-enabled digital fingerprint technology, the health tech pioneer’s latest, patent-pending innovation shores up a longstanding point of vulnerability: the risk of a prescriber’s identity information being used by bad actors to gain access to medical credentials and commit prescription fraud. There has been no system to aid pharmacists who receive fraudulent prescriptions.
TrueRx’s algorithms learn prescribing behaviors associated with registered prescribers nationwide. When a prescription arrives at the pharmacy, digital fingerprint analysis alerts the pharmacist if one or more “behavior outliers” are detected that are typical in cases of stolen identity. As methods of identity fraud become more complex, the algorithms will learn new behaviors to better prepare for the next style of attack.
“In much the same way that credit monitoring uses data to validate that consumers are who they claim to be, we can now do the same for prescribers and pharmacists,” said Colin Banas, M.D., M.H.A., chief medical officer for DrFirst. “Our platform is the first in the industry to monitor prescriber trends and track data for prescriber location, medication types, and volume – data that tells us when something’s not quite right so we can give pharmacies what they need to protect patients and providers. An added benefit is it creates more efficient and safe workflows between pharmacists and providers.”
Incidents of prescriber identity theft have been documented for about 10% of the 1 million prescribers in the U.S. Bad actors aren’t just targeting controlled substances, such as opioids and narcotics; they also focus on high-cost specialty medications, including AIDS drugs, popular weight loss injectables, and powerful cancer therapies.
A 2023 survey from iPrescribe by DrFirst reveals a disconnect between providers’ concerns about security and how they store and protect their credentials.
While half of providers said they are very or extremely concerned about prescriber identity protection, more than two-thirds (71%) said they don’t monitor for identity theft, and nearly 80% do not store their records securely.
When asked their level of concern about identity fraud, prescribers ranked it as:
In spite of these concerns, prescribers say they use non-secure methods to store their medical credentials, including:
Prescriber identity is a significant problem in the digital age of healthcare, but not for the reasons we might think, according to Banas.
“The expectation that e-prescribing would solve the problem of stolen paper prescription pads didn’t account for how advanced identity risk has become in the digital age,” he said. “The safeguards in place for digital prescribing hold up to the pervasive attacks we see today, but what people – including doctors – do on the Internet in their personal lives is still connected with everything in their professional lives. So, it’s especially risky to use just one password to secure your identity as a provider.”
Banas said there’s plenty that healthcare providers can do right now to secure their prescriber identity from the threat of theft and fraud, including:
Methodology
iPrescribe by DrFirst surveys explore consumers’ perspectives about medication use and healthcare in the U.S. A national survey of 779 licensed U.S. prescribers within the DrFirst network was conducted by TechValidate on behalf of iPrescribe by DrFirst in May 2023. Survey responses were gathered from a range of clinician prescribers, including medical doctors, nurse practitioners, physician associates, and dentists, among others.
About iPrescribe and DrFirst
iPrescribe by DrFirst is the industry-leading mobile prescribing app used by doctors, dentists, physician assistants, and nurse practitioners to quickly and safely prescribe and renew prescriptions anytime, anywhere. Since 2000, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. We improve healthcare efficiency and effectiveness by enhancing e-prescribing workflows, improving medication history, optimizing clinical data usability, and helping patients start and stay on therapy. In the last few years, DrFirst has won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of clinical-grade AI to streamline time-consuming healthcare workflows and prevent medication errors. Our solutions are used by more than 350,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. and Canada. To learn more, visit DrFirst.com and follow @DrFirst.
Fonte: Business Wire
Scheduled for October, the world's largest startup event will bring together more than 2,000 exhibitors in Dubai, UAE
The Italian IoT company is in the US for the second phase of CALL4INNOVIT
The Italian company partners with MainStreaming for high-performance, energy-efficient video streaming
Software vendors developing vertical solutions against specific attack vectors are 'cool' again. And when it comes to email security, all companies now…
The "New Zealand Buy Now Pay Later Business and Investment Opportunities Databook - Q2 2024 Update" report has been added to ResearchAndMarkets.com's…
The "Kenya Buy Now Pay Later Business and Investment Opportunities Databook - 75+ KPIs on BNPL Market Size, End-Use Sectors, Market Share, Product Analysis,…
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) will host two live webcasts on September 5, 2024.…
RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces that Mark Lawyer has joined…